ESPAC-4: A multicenter, international, open label...

Pancreatology 2016 / 06 Vol. 16; Iss. 3

ESPAC-4: A multicenter, international, open label randomized controlled phase III trial of adjuvant combination chemotherapy of gemcitabine (GEM) and capecitabine (CAP), versus monotherapy gemcitabine in patients with resected pancreatic ductal adenocarcinoma

Neoptolemos, J., Palmer, D., Ghaneh, P., Valle, J.W., Cunningham, D., Wadsley, J., Meyer, T., Anthoney, A., Glimelius, B., Falk, S., Segersvärd, R., Izbicki, J., Middleton, G., Ross, P., Wasan, H., Mc
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
16
Language:
english
Journal:
Pancreatology
DOI:
10.1016/j.pan.2016.05.215
Date:
June, 2016
File:
PDF, 46 KB
english, 2016
Conversion to is in progress
Conversion to is failed